Alpha-gal Allergen Inclusion Act
Summary
What This Bill Does
The Alpha-gal Allergen Inclusion Act adds galactose-alpha-1,3-galactose, commonly known as alpha-gal, to the federal definition of major food allergen. The definition includes ingredients derived from non-catarrhine primate mammals and red algae in the order Gigartinales, while allowing the Secretary to exclude mammal-derived ingredients when no alpha-gal is present above an established detectable limit, such as ingredients from alpha-gal-knockout mammals. The labeling change applies 18 months after enactment. The bill gives consumers with alpha-gal syndrome stronger food-label visibility while imposing reformulation, labeling, and compliance work on food manufacturers.
Who Benefits and How
People with alpha-gal syndrome benefit because covered foods must treat alpha-gal as a major allergen. Allergy clinicians benefit from clearer labeling that can help patients avoid reactions to mammal-derived or covered red-algae ingredients. Food shoppers with mammalian-product sensitivities benefit from a standardized federal disclosure rule. Consumer safety advocates benefit from adding a medically significant allergen to the national labeling framework.
Who Bears the Burden and How
Food manufacturers must identify alpha-gal-containing ingredients, update labels, and manage the 18-month transition. FDA food-labeling staff must implement the new allergen definition and make detectable-limit determinations. Ingredient suppliers must provide more information about mammal-derived and red-algae ingredients. Restaurants and packaged-food sellers may face consumer questions and supply-chain compliance pressure.
Key Provisions
- Adds alpha-gal to the federal definition of major food allergen.
- Includes mammal-derived ingredients and covered red algae in the alpha-gal definition.
- Allows the Secretary to exclude ingredients with no detectable alpha-gal above an established limit.
- Requires the allergen-labeling change to apply 18 months after enactment.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
Adds alpha-gal to the Food, Drug, and Cosmetic Act definition of major food allergen with an 18-month effective date.
Key Policy Areas
Food Safety, Health Care, Consumer Protection
Primary Purpose
Adds alpha-gal to the Food, Drug, and Cosmetic Act definition of major food allergen with an 18-month effective date.
Policy Domains
Resolution provisions
Identified Gains
- People with alpha-gal syndrome
- Allergy clinicians
- Food shoppers with sensitivities
- Consumer safety advocates
Identified Costs
- Food manufacturers
- FDA food-labeling staff
- Ingredient suppliers
- Packaged-food sellers
Sponsors
Legislative Progress
In CommitteeMr. Van Drew (for himself, Mr. Murphy, Mr. Davis of …
Referred to the House Committee on Energy and Commerce.
Introduced in House
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Allergy clinicians, People with alpha-gal syndrome
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology